Allworth Financial
CSTL icon

Allworth Financial’s Castle Biosciences CSTL Stock Holding History

Allworth Financial’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$22.4K Buy
938
+674
+255% +$20.3K ﹤0.01% 3242
2026
Q2 		$6.3K Buy
264
+201
+319% +$4.48K ﹤0.01% 3997
2026
Q1 		$1.55K Buy
63
+33
+110% +$1.08K ﹤0.01% 4432
2025
Q4 		$1.17K Buy
30
+11
+58% +$355 ﹤0.01% 4315
2025
Q3 		$433 Buy
19
+14
+280% +$284 ﹤0.01% 4473
2025
Q2 		$103 Buy
+5
New +$93 ﹤0.01% 4397
2023
Q4 		– Sell
-41
Closed -$693 – 3494
2023
Q3 		$693 Sell
41
-33
-45% -$577 ﹤0.01% 2959
2023
Q2 		$1.02K Sell
74
-57
-44% -$1.16K ﹤0.01% 2729
2023
Q1 		$2.98K Buy
131
+123
+1,538% +$3K ﹤0.01% 2242
2022
Q4 		$188 Hold
8
– – ﹤0.01% 2795
2022
Q3 		$0 Hold
8
– – ﹤0.01% 2735
2022
Q2 		$0 Buy
+8
New +$186 ﹤0.01% 2469

Other funds holding CSTL

Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Jefferies Financial Group
Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return
Wasatch Advisors
Wasatch Advisors Salt Lake City, Utah $13.5B AUM 16.58% 1-Year Est. Return
Kornitzer Capital Management
Kornitzer Capital Management Shawnee Mission, Kansas $4.8B AUM 30.14% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Perkins Capital Management
Perkins Capital Management Wayzata, Minnesota $140M AUM 109.55% 1-Year Est. Return

Allworth Financial's CSTL Position: Q3 2026 in Review

Allworth Financial increased its Castle Biosciences (CSTL) stake by 255% in Q3 2026, buying an estimated $20.3K and bringing the position to 938 shares worth $22.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3242.

Allworth Financial first reported a position in CSTL in Q2 2022 and has held it in 12 quarters since. 74 funds tracked by Wall St. Rank hold CSTL as of Q3 2026.

  • Allworth Financial held 938 shares of Castle Biosciences worth $22.4K as of Q3 2026.
  • Allworth Financial bought 674 Castle Biosciences shares in Q3 2026, an estimated $20.3K.
  • Castle Biosciences made up ﹤0.01% of Allworth Financial's portfolio in Q3 2026, its #3242 holding.
  • Allworth Financial first reported a position in Castle Biosciences in Q2 2022 and has held it in 12 quarters since.
  • 74 funds tracked by Wall St. Rank held Castle Biosciences as of Q3 2026.

Based on Allworth Financial's 13F filing for Q3 2026, filed 6 Nov 2026.